Marker Exploration Corporation (Marker X) is a biotech company dedicated to discovering novel disease biomarkers. As is widely known, early detection and early treatment are the cornerstones of modern medicine. Marker X utilizes cutting-edge mass spectrometry and proteomic approaches to offer non-invasive early cancer screening. Therefore, we specialize in precision medicine for multiple cancer screenings. Our features include: 1. Cancer can be detected by blood drawing 2. Cancer can be detected at early stage 3. A single blood drawing can be used to check for multiple cancers. Besides cancer screening, we will provide our service to other chronic diseases in the near future, like early alarm of heart disease. It may support physicians in diagnosis and early intervention. In addition, a companion diagnosis that related to medication is also being developed to help physicians and patients to make decision before treatment. The long-term goal of Marker X is to prevent disease at the very early stage through early detection. Using our services and products can bring people a healthy and high-quality life.
